Sino-Agri Leading Biosciences Co.,Ltd (SHA:603970)
China · Delayed Price · Currency is CNY 9.99
-0.01 (-0.10%)
Nov 9, 2026, 3:00 PM CST
SHA:603970 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 240.47 | 249.73 | 405.31 | 864.09 | 1,932 | 966.97 |
Short-Term Investments | - | 5.53 | - | - | - | - |
Trading Asset Securities | 463.41 | 864.33 | 1,000 | 792.2 | 1,000 | 506.93 |
Cash & Short-Term Investments | 703.88 | 1,120 | 1,405 | 1,656 | 2,932 | 1,474 |
Cash Growth | 121.99% | -20.33% | -15.15% | -43.50% | 98.91% | -2.28% |
Accounts Receivable | 2,182 | 1,512 | 1,692 | 1,708 | 320.93 | 199.29 |
Other Receivables | 54.96 | 27.51 | 49.42 | 59.03 | 116.35 | 37.94 |
Receivables | 2,237 | 1,539 | 1,741 | 1,767 | 437.29 | 237.23 |
Inventory | 1,907 | 1,470 | 1,573 | 1,536 | 1,563 | 1,716 |
Other Current Assets | 773.06 | 518.94 | 633.58 | 779.25 | 1,047 | 1,077 |
Total Current Assets | 5,621 | 4,648 | 5,353 | 5,738 | 5,979 | 4,504 |
Property, Plant & Equipment | 53.87 | 48.06 | 58.53 | 71.84 | 60.39 | 73.77 |
Long-Term Investments | 155.8 | 166.89 | 137.09 | 99.13 | 113.2 | 86.17 |
Other Intangible Assets | 2.63 | 3.08 | 3.65 | 4.29 | 5.14 | 50.53 |
Long-Term Deferred Tax Assets | 47.83 | 42.46 | 43.95 | 50.38 | 44.72 | 25.3 |
Long-Term Deferred Charges | 1.72 | 3.21 | 5.67 | 2.53 | 1.48 | 1.69 |
Other Long-Term Assets | - | - | - | 42 | 42 | - |
Total Assets | 5,883 | 4,911 | 5,602 | 6,008 | 6,246 | 4,742 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2,337 | 1,478 | 2,118 | 2,759 | 2,648 | 1,298 |
Accrued Expenses | 42.21 | 88.2 | 83.75 | 81.12 | 75.32 | 40.48 |
Short-Term Debt | 311.99 | 558.02 | 628.48 | 628.87 | 800.73 | 942 |
Current Portion of Long-Term Debt | 9.68 | - | - | 100.08 | 0.09 | - |
Current Portion of Leases | - | 3.67 | 8.73 | 10.05 | 3.5 | 9.71 |
Current Income Taxes Payable | 61.71 | 26.28 | 25.19 | 30.86 | 55.09 | 24.68 |
Current Unearned Revenue | 1,245 | 918.36 | 897.8 | 624.42 | 932.11 | 893.39 |
Other Current Liabilities | 86.88 | 80.32 | 139.55 | 152.86 | 116.85 | 221.24 |
Total Current Liabilities | 4,095 | 3,152 | 3,901 | 4,388 | 4,632 | 3,429 |
Long-Term Debt | - | - | - | - | 100 | - |
Long-Term Leases | 13.44 | 9.29 | 4.32 | 9.29 | 5.61 | 5.46 |
Long-Term Unearned Revenue | 1.14 | 1.62 | 0.15 | 0.33 | - | 8.39 |
Long-Term Deferred Tax Liabilities | 15.72 | 15.49 | 9.74 | 12.58 | 18.18 | 12.11 |
Other Long-Term Liabilities | 4.46 | 4.46 | 4.28 | 4.28 | 6.01 | 5.59 |
Total Liabilities | 4,130 | 3,183 | 3,920 | 4,414 | 4,762 | 3,461 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 268.8 | 268.8 | 268.8 | 268.8 | 192 | 192 |
Additional Paid-In Capital | 238.23 | 238.23 | 238.23 | 238.23 | 302.15 | 298.02 |
Retained Earnings | 1,087 | 1,044 | 992.72 | 910.31 | 791.07 | 648.12 |
Comprehensive Income & Other | 7.65 | 24.7 | 20.69 | 22.2 | 32.93 | 33 |
Total Common Equity | 1,602 | 1,576 | 1,520 | 1,440 | 1,318 | 1,171 |
Minority Interest | 151.26 | 152.22 | 162.24 | 154.62 | 166.2 | 109.75 |
Shareholders' Equity | 1,753 | 1,728 | 1,683 | 1,594 | 1,484 | 1,281 |
Total Liabilities & Equity | 5,883 | 4,911 | 5,602 | 6,008 | 6,246 | 4,742 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 335.11 | 570.98 | 641.53 | 748.28 | 909.93 | 957.18 |
Net Cash (Debt) | 368.78 | 548.61 | 763.78 | 908.02 | 2,022 | 516.72 |
Net Cash Growth | - | -28.17% | -15.88% | -55.09% | 291.28% | 34.71% |
Net Cash Per Share | 1.37 | 2.04 | 2.84 | 3.38 | 7.52 | 1.92 |
Filing Date Shares Outstanding | 268.75 | 268.8 | 268.8 | 268.8 | 268.8 | 268.8 |
Total Common Shares Outstanding | 268.75 | 268.8 | 268.8 | 268.8 | 268.8 | 268.8 |
Working Capital | 1,526 | 1,495 | 1,452 | 1,350 | 1,347 | 1,075 |
Book Value Per Share | 5.96 | 5.86 | 5.66 | 5.36 | 4.90 | 4.36 |
Tangible Book Value | 1,600 | 1,573 | 1,517 | 1,435 | 1,313 | 1,121 |
Tangible Book Value Per Share | 5.95 | 5.85 | 5.64 | 5.34 | 4.88 | 4.17 |
Buildings | - | 28.31 | 28.31 | 17.54 | 17.54 | 17.54 |
Machinery | - | 84.72 | 87.7 | 89.14 | 95.86 | 98.37 |
Construction In Progress | - | - | - | 9.32 | - | - |